Funds holding Generate Biomedicines Inc
ISIN US3709201004 · United States
- Fund holders
- 24
- Of which ETFs
- 1 23 other funds
- Value held
- 83.6M $
- Share of capital
- 5.2 % of 128.4M shares on Jul 29, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 3,650,034 | 45.6M $ | 0.06 % | 2.84 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 596,468 | 7.5M $ | 0.34 % | 0.46 % | as of Mar 31, 2026 ↗ |
| ARK Genomic Revolution ETF ARK ETF Trust | 503,531 | 6.4M $ | 0.51 % | 0.39 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 493,741 | 6.2M $ | 0.54 % | 0.38 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 391,168 | 4.9M $ | 0.53 % | 0.30 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 265,641 | 3.3M $ | 0.03 % | 0.21 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 192,755 | 2.4M $ | 0.17 % | 0.15 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 131,034 | 1.6M $ | 0.53 % | 0.10 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 96,876 | 1.2M $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 85,927 | 1.1M $ | 0.53 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 58,335 | 729.2K $ | 0.26 % | 0.05 % | as of Mar 31, 2026 ↗ |
| U.S. Small and Mid Cap Equity Fund AMERICAN FUNDS INSURANCE SERIES | 39,715 | 496.4K $ | 0.51 % | 0.03 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 33,776 | 422.2K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 31,223 | 390.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 18,838 | 235.5K $ | 0.18 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 18,234 | 227.9K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 17,700 | 221.3K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 16,043 | 200.5K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 12,700 | 158.8K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Managed Volatility Fund II Federated Hermes Insurance Series | 9,000 | 112.5K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Muni and Stock Advantage Fund Federated Hermes Income Securities Trust | 8,500 | 107.4K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Prudent Bear Fund Federated Hermes Equity Funds | 5,000 | 62.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 1,747 | 21.8K $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 1,473 | 18.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 0.54 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 0.53 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.53 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 0.53 % | as of Mar 31, 2026 ↗ |
| ARK Genomic Revolution ETF ARK ETF Trust | 0.51 % | as of Apr 30, 2026 ↗ |
| U.S. Small and Mid Cap Equity Fund AMERICAN FUNDS INSURANCE SERIES | 0.51 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 0.34 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 0.26 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 0.18 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 0.17 % | as of Mar 31, 2026 ↗ |
Institutional managers
54 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Flagship Pioneering, LLC | 62,673,117 | 783.4M $ | as of Mar 31, 2026 |
| FMR LLC | 4,217,524 | 52.7M $ | as of Mar 31, 2026 |
| Capital World Investors | 4,004,149 | 50.1M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 3,592,999 | 44.9M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,947,259 | 33.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,109,633 | 26.4K $ | as of Mar 31, 2026 |
| ARCH Venture Management, LLC | 1,944,426 | 24.3M $ | as of Mar 31, 2026 |
| HarbourVest Partners LLC | 1,722,210 | 21.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,423,602 | 17.8M $ | as of Mar 31, 2026 |
| HARVARD MANAGEMENT CO INC | 1,111,100 | 13.9M $ | as of Mar 31, 2026 |
| NVIDIA CORP | 833,325 | 10.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 736,104 | 9.2M $ | as of Mar 31, 2026 |
| Davern Capital Partners, LP | 591,800 | 7.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 500,000 | 6.3M $ | as of Mar 31, 2026 |
| ARK Investment Management LLC | 498,408 | 6.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 376,893 | 4.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 356,704 | 4.5M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 350,000 | 4.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 337,302 | 4.2M $ | as of Mar 31, 2026 |
| ExodusPoint Capital Management, LP | 311,986 | 3.9M $ | as of Mar 31, 2026 |
| CenterBook Partners LP | 266,813 | 3.3M $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 185,000 | 2.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 170,695 | 2.1M $ | as of Mar 31, 2026 |
| SEVEN GRAND MANAGERS, LLC | 125,000 | 1.6M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 123,371 | 1.5M $ | as of Mar 31, 2026 |
Declared shareholders of Generate Biomedicines Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Flagship Pioneering Fund VI, L.P. and 14 others | 48.90 % | 62,701,915 | as of Mar 31, 2026 · SCHEDULE 13G |
| Nally Michael | 5.20 % | 6,919,051 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Generate Biomedicines Inc". https://titelia.com/en/stocks/generate-biomedicines-inc-US3709201004